The Study of the Treatment for Chronic Pain with Human Mesenchymal Stem Cell Conditioned Medium

OSAKA UMEDA KENBI CLINIC0 个研究点开始时间: 待定最近更新: 2024年5月7日

试验速览

暂无简介。

•Those for whom satisfactory improvement effects were not observed with standard therapy.
•Individuals who do not wish to undergo treatment with drugs commonly used in standard therapy due to concerns about side effects, and have been deemed suitable for treatment with conditioned medium by a physician.
•The patient selection criteria are as follows:
•<Inclusion Criteria>
•Patients meeting the following criteria will be considered eligible:
•Individuals aged 18 and above.
•Individuals with normal decision-making capacity.
•Individuals who have been provided with the informed consent document regarding this treatment, received sufficient explanation, and can provide voluntary written consent.
•Individuals for whom the attending physician has recognized the necessity of treatment."

•"<Exclusion Criteria>
•Individuals meeting any of the following conditions will be excluded from the study:
•Users of narcotics or stimulants.
•Individuals deemed inappropriate by the attending physician"

发起方

OSAKA UMEDA KENBI CLINIC